Ostacher M

US Department of Veterans Affairs Palo Alto Health Care System, USA; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford University, Stanford, CA, USA.

3 papers · ORCID

ArticlePsilocybin

Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression.

Kelly CM, Fradet M, Bostian CM +5

Europe PMC2026

ArticlePsilocybin

Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot study.

Ellis S, Bostian C, Donnelly A +7

Europe PMC2025

ArticlePsilocybin

Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study.

Ellis S, Bostian C, Feng W +8

Europe PMC2025